Christopher Cleary's Insider Trades & SAST Disclosures

Christopher Cleary's most recent trade in Orchestra BioMed Holdings Inc was a trade of 30,742 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Orchestra BioMed Holdings Inc
Christopher Cleary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 30,742 30,742 - - Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc
Christopher Cleary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 10,155 10,155 - 0 Common Stock, par value $0.0001 per share ("Common Stock")
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades